Division of Nephrology, University of Michigan, Ann Arbor, MI, USA.
Department of Kidney Medicine, Glickman Urological & Kidney Institute, Cleveland, OH, USA.
J Vasc Access. 2024 Mar;25(2):546-550. doi: 10.1177/11297298221106853. Epub 2022 Oct 6.
The COVID-19 pandemic has adversely affected health care systems and dialysis access care in the US and across the globe. Beyond the initial challenges posed by the pandemic and despite the actions taken by health care leaders/organizations/professional societies such as the "Maintaining Lifelines for ESKD Patients" joint statement, there continues to be delays in providing timely care and performing elective and emergent dialysis access procedures worldwide. The aim of this study was to assess the global challenges associated with providing dialysis vascular access care across the international vascular access community during the pandemic.
The American Society of Diagnostic and Interventional Nephrology (ASDIN) conducted an online survey in 2021, that was administered to an expert panel of dialysis vascular access specialists and global leaders spanning across the international community. The respondents who are members of ASDIN, Association of Vascular Access and InTerventionAl Renal physicians (AVATAR), Asia Pacific Society of Dialysis Access (APSDA), Peruvian Vascular Access Society (APDAV), and Australia/New Zealand Society of Interventional Nephrology (ANZSIN) reported their experiences in the care of dialysis vascular access, practice patterns, and challenges faced during the COVID pandemic.
Of the 53 individual surveys sent, 16 were opened and 11 (69%) responses were received from across the world and from different practice settings. The survey revealed the continued challenges facing the international community, the stark disparities in care delivery, supply chain disruption and logistical, regulatory, and financial issues that the global community continues to face in the ongoing pandemic.
The COVID19 pandemic is far from over, and the challenges and barriers to providing dialysis access care seen on the initial ASDIN survey in the US seem to extend across the globe. We describe those results and discuss options, opportunities, and innovative tools to provide dialysis and access care during these trying times.
COVID-19 大流行对美国和全球的医疗保健系统和透析通路护理产生了不利影响。除了大流行最初带来的挑战,以及尽管医疗保健领导者/组织/专业协会(如“维持终末期肾病患者生命线”联合声明)采取了行动,但在全球范围内,提供及时的护理以及进行选择性和紧急透析通路手术的工作仍在继续延迟。本研究旨在评估在大流行期间国际血管通路界提供透析血管通路护理所面临的全球挑战。
美国诊断与介入肾脏病学会(ASDIN)于 2021 年进行了一项在线调查,该调查针对透析血管通路专家和全球领导人的专家小组进行,这些领导人跨越国际社会。作为 ASDIN、血管通路和介入性肾脏医师协会(AVATAR)、亚太透析通路学会(APSDA)、秘鲁血管通路学会(APDAV)和澳大利亚/新西兰介入性肾脏病学会(ANZSIN)成员的受访者报告了他们在透析血管通路护理、实践模式方面的经验,以及在 COVID 大流行期间面临的挑战。
在发出的 53 份个人调查中,有 16 份被打开,收到了来自世界各地不同实践环境的 11 份(69%)回复。该调查揭示了国际社会面临的持续挑战、护理提供方面的明显差异、供应链中断以及全球社会在持续大流行中继续面临的后勤、监管和财务问题。
COVID19 大流行远未结束,美国 ASDIN 最初调查中看到的提供透析通路护理的挑战和障碍似乎在全球范围内都存在。我们描述了这些结果,并讨论了在这些困难时期提供透析和通路护理的选择、机会和创新工具。